FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma

Mashaal Dhir, Mazen S. Zenati, Ahmad Hamad, Aatur D. Singhi, Nathan Bahary, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat

Research output: Contribution to journal › Article › peer-review